A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy

Adalimumab is a recombinant monoclonal antibody to tumor necrosis factor alpha (TNFα) used in the treatment of inflammatory and autoimmune conditions, including ulcerative colitis (UC). Adverse side effects include infection and injection-site cutaneous reactions; however, rare adverse events such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Leonard T, Patel, Ravi, Loloi, Justin, Jones, Kirk, Caler, Julie, Ayaz, Zain, Jain, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318094/
https://www.ncbi.nlm.nih.gov/pubmed/30648028
http://dx.doi.org/10.7759/cureus.3477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318094/
https://www.ncbi.nlm.nih.gov/pubmed/30648028
http://dx.doi.org/10.7759/cureus.3477

Ejemplares similares